RNS Number : 4617SAgronomics Limited10 March 2023

London, UK, 10 March 2023


Edison issues update on Agronomics (ANIC)

Agronomics invests in cellular agriculture companies. Since mid-2022 it has placed increasing emphasis on companies using precision fermentation technology or providing contract precision fermentation services, as these appear to have greater near-term commercial potential than cultivated meat and seafood. Agronomics' NAV has risen almost 100% since the inception of the current strategy in April 2019, and looks set to increase further as the company's portfolio holdings receive regulatory approval for their products and/or begin generating income. ANIC is the only UK-listed vehicle targeting cellular agriculture, thus offering investors a rare opportunity to gain exposure to this exciting and rapidly expanding, but difficult to access, sector. The company is trading at a rare discount to NAV, providing investors with a chance to gain exposure at a particularly attractive price.

ANIC's share price is trading at an uncharacteristic discount to cum-income NAV, for reasons that, arguably, have little do with the company's performance. In our view, this situation provides investors with an opportunity that is unlikely to persist for too long, due to the increasing appetite for sustainable investments and the scarcity of alternative investment options in the cellular agriculture sector. The potential of eventual valuation uplifts to ANIC's portfolio holdings should also support the share price and diminish the discount over time.


Click here to view the full report or here to sign up to receive research as it is published.

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by theFinancial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Joanne Collins +44 (0)20 3077 5700 [email protected]

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn        www.linkedin.com/company/edison-group-/

Twitterwww.twitter.com/Edison_Inv_Res

YouTube       www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. ENDNRAEAFDNEEXDEFA

==